Brain Res. 1995 Sep 18;692(1-2):269-72.

Brain dopamine transporter: gender differences and effect of chronic haloperidol.

Source

School of Pharmacy, Laval University, Quebec, Canada.

Abstract

Gender differences and the effect of chronic haloperidol on the rat brain dopamine transporter is reported. The density of striatal dopamine transporter sites labelled with [3H]GBR 12935, and of substantia nigra dopamine transporter mRNA measured by in situ hybridization were higher in female compared to male rats whereas striatal D2 specific binding labelled with [3H]spiperone was not significantly higher. Daily haloperidol treatment (1 mg/kg, i.p.) for 21 days increased striatal [3H]spiperone specific binding but left unchanged striatal [3H]GBR 12935 binding density and affinity as well as substantia nigra dopamine transporter mRNA levels. A reduce clearance rate of dopamine in the striatum after acute and chronic haloperidol was previously reported; the present results indicate that this may occur without changes in the sites of dopamine transport or in gene expression of this transporter.

PMID:: 8548314; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

HALOPERIDOL - HSDB

Supplemental Content

Save items

Related citations in PubMed

Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants. [Neuroscience. 2001]
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Cyr M, Morissette M, Barden N, Beaulieu S, Rochford J, Di Paolo T. Neuroscience. 2001; 102(1):151-8.
Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat. [Br J Pharmacol. 1999]
Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
Régo JC, Syringas M, Leblond B, Costentin J, Bonnet JJ. Br J Pharmacol. 1999 Sep; 128(1):51-60.
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. [Synapse. 1999]
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T. Synapse. 1999 Jun 1; 32(3):153-64.
Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration. [Mol Neurobiol. 1995]
Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
Claye LH, Akunne HC, Davis MD, DeMattos S, Soliman KF. Mol Neurobiol. 1995 Aug-Dec; 11(1-3):55-66.
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. [J Neurochem. 1999]
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR. J Neurochem. 1999 Jan; 72(1):148-56.

See reviews... See all...

Cited by 8 PubMed Central articles

Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats. [Pharmacol Biochem Behav. 2009]
Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats.
Harrod SB, Van Horn ML. Pharmacol Biochem Behav. 2009 Dec; 94(2):296-304. Epub 2009 Sep 17.
Review Sex, gender, and pain: a review of recent clinical and experimental findings. [J Pain. 2009]
Review Sex, gender, and pain: a review of recent clinical and experimental findings.
Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL 3rd. J Pain. 2009 May; 10(5):447-85.
In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. [Neuroscience. 2009]
In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex.
Meyers B, Kritzer MF. Neuroscience. 2009 Mar 3; 159(1):271-82. Epub 2008 Dec 14.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Brain dopamine transporter: gender differences and effect of chronic haloperidol...
Brain dopamine transporter: gender differences and effect of chronic haloperidol.
Brain Res. 1995 Sep 18 ;692(1-2):269-72.

PubMed
Herpes simplex virus resistance to acyclovir: clinical relevance.
Herpes simplex virus resistance to acyclovir: clinical relevance.
Infect Agents Dis. 1995 Sep ;4(3):115-24.

PubMed
Preventing bacterial respiratory tract infections among persons infected with hu...
Preventing bacterial respiratory tract infections among persons infected with human immunodeficiency virus.
Clin Infect Dis. 1995 Aug ;21 Suppl 1:S77-83.

PubMed
Structural and functional analysis of the human phosphoenolpyruvate carboxykinas...
Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter.
Biochim Biophys Acta. 1995 Dec 27 ;1264(3):284-8.

PubMed
[Psychodynamic aspects of paraphrenia].
[Psychodynamic aspects of paraphrenia].
Schweiz Arch Neurol Neurochir Psychiatr. 1977 ;120(1):101-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: